Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 1
2007 4
2008 1
2009 3
2010 3
2011 3
2012 6
2013 3
2014 5
2015 3
2016 2
2017 2
2018 3
2019 3
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, Droller MJ; PC B302/01 Study Group. Fradet Y, et al. J Urol. 2007 Jul;178(1):68-73; discussion 73. doi: 10.1016/j.juro.2007.03.028. Epub 2007 May 11. J Urol. 2007. PMID: 17499291 Clinical Trial.
PURPOSE: We compared hexaminolevulinate (Hexvix) fluorescence cystoscopy with white light cystoscopy for detecting carcinoma in situ. ...Hexaminolevulinate instillation was well tolerated with no local or systemic side effects. ...
PURPOSE: We compared hexaminolevulinate (Hexvix) fluorescence cystoscopy with white light cystoscopy for detecting carcinoma in situ. …
Photodynamic therapy of cervical intraepithelial neoplasia 1-3 and human papilloma virus (HMV) infection with methylaminolevulinate and hexaminolevulinate--a double-blind, dose-finding study.
Soergel P, Dahl GF, Onsrud M, Hillemanns P. Soergel P, et al. Lasers Surg Med. 2012 Aug;44(6):468-74. doi: 10.1002/lsm.22041. Epub 2012 Jun 12. Lasers Surg Med. 2012. PMID: 22693121 Clinical Trial.
MATERIAL AND METHODS: Patients were treated by PDT using hexaminolevulinate (HAL) and methylaminolevulinate in six dose and light groups and two incubation periods in a double-blind setting. ...
MATERIAL AND METHODS: Patients were treated by PDT using hexaminolevulinate (HAL) and methylaminolevulinate in six dose and light gro …
Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasia.
Hillemanns P, Petry KU, Soergel P, Collinet P, Ardaens K, Gallwas J, Luyten A, Dannecker C. Hillemanns P, et al. Lasers Surg Med. 2014 Aug;46(6):456-61. doi: 10.1002/lsm.22255. Epub 2014 May 6. Lasers Surg Med. 2014. PMID: 24799181 Clinical Trial.
The aim of this study was to assess the efficacy and safety of hexaminolevulinate (HAL) photodynamic therapy (PDT) in the treatment of patients with CIN 1. ...
The aim of this study was to assess the efficacy and safety of hexaminolevulinate (HAL) photodynamic therapy (PDT) in the treatment o …
Effect of blue-light cystoscopy on contemporary performance of urine cytology.
Freifeld Y, Lotan Y. Freifeld Y, et al. BJU Int. 2019 Aug;124(2):251-257. doi: 10.1111/bju.14574. Epub 2018 Oct 21. BJU Int. 2019. PMID: 30281893 Clinical Trial.
MATERIALS AND METHODS: Individual patient data were obtained from three prospective studies: the Photocure (PC) B305 and the PC B308 studies, evaluating the use of blue-light cystoscopy with hexaminolevulinate (BLC-H), and the Cxbladder monitoring study, evaluating the Cxb …
MATERIALS AND METHODS: Individual patient data were obtained from three prospective studies: the Photocure (PC) B305 and the PC B308 studies …
Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate.
Soergel P, Wang X, Stepp H, Hertel H, Hillemanns P. Soergel P, et al. Lasers Surg Med. 2008 Nov;40(9):611-5. doi: 10.1002/lsm.20686. Lasers Surg Med. 2008. PMID: 18951428 Clinical Trial.
This study assessed the feasibility and response rate of PDT with hexaminolevulinate (HAL) in cervical intraepithelial neoplasia (CIN) and human papillomavirus (HPV) infection. ...
This study assessed the feasibility and response rate of PDT with hexaminolevulinate (HAL) in cervical intraepithelial neoplasia (CIN …
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study.
Daneshmand S, Patel S, Lotan Y, Pohar K, Trabulsi E, Woods M, Downs T, Huang W, Jones J, O'Donnell M, Bivalacqua T, DeCastro J, Steinberg G, Kamat A, Resnick M, Konety B, Schoenberg M, Jones JS; Flexible Blue Light Study Group Collaborators. Daneshmand S, et al. J Urol. 2018 May;199(5):1158-1165. doi: 10.1016/j.juro.2017.11.096. Epub 2017 Dec 2. J Urol. 2018. PMID: 29203268 Clinical Trial.
MATERIALS AND METHODS: Patients at high risk for recurrence received hexaminolevulinate intravesically before white light flexible cystoscopy and randomization to blue light flexible cystoscopy. ...
MATERIALS AND METHODS: Patients at high risk for recurrence received hexaminolevulinate intravesically before white light flexible cy …
Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
Geavlete B, Multescu R, Georgescu D, Jecu M, Stanescu F, Geavlete P. Geavlete B, et al. BJU Int. 2012 Feb;109(4):549-56. doi: 10.1111/j.1464-410X.2011.10374.x. Epub 2011 Jun 28. BJU Int. 2012. PMID: 21711438 Clinical Trial.
OBJECTIVES: To evaluate in a prospective, randomized study the impact of hexaminolevulinate blue-light cystoscopy (HAL-BLC) on the diagnostic accuracy and treatment changes in cases of non-muscle invasive bladder cancer (NMIBC) compared with standard white-light cystoscopy …
OBJECTIVES: To evaluate in a prospective, randomized study the impact of hexaminolevulinate blue-light cystoscopy (HAL-BLC) on the di …
Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).
Bader MJ, Stepp H, Beyer W, Pongratz T, Sroka R, Kriegmair M, Zaak D, Welschof M, Tilki D, Stief CG, Waidelich R. Bader MJ, et al. Urol Oncol. 2013 Oct;31(7):1178-83. doi: 10.1016/j.urolonc.2012.02.007. Epub 2012 Mar 21. Urol Oncol. 2013. PMID: 22440147 Clinical Trial.
OBJECTIVES: To assess the safety and feasibility of hexaminolevulinate (HAL) based photodynamic therapy (PDT) as adjuvant treatment after transurethral resection of the bladder (TURB) in patients with intermediate or high-risk urothelial cell carcinoma (UCC) of the bladder …
OBJECTIVES: To assess the safety and feasibility of hexaminolevulinate (HAL) based photodynamic therapy (PDT) as adjuvant treatment a …
A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2.
Hillemanns P, Garcia F, Petry KU, Dvorak V, Sadovsky O, Iversen OE, Einstein MH. Hillemanns P, et al. Am J Obstet Gynecol. 2015 Apr;212(4):465.e1-7. doi: 10.1016/j.ajog.2014.10.1107. Epub 2014 Oct 31. Am J Obstet Gynecol. 2015. PMID: 25467012 Clinical Trial.
OBJECTIVE: The objective of the study was to investigate the efficacy and safety of hexaminolevulinate (HAL) photodynamic therapy (PDT), a novel therapy for women with cervical intraepithelial neoplasia (CIN)1/2, to define the appropriate population and endpoints for a pha …
OBJECTIVE: The objective of the study was to investigate the efficacy and safety of hexaminolevulinate (HAL) photodynamic therapy (PD …
Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.
Inoue K, Anai S, Fujimoto K, Hirao Y, Furuse H, Kai F, Ozono S, Hara T, Matsuyama H, Oyama M, Ueno M, Fukuhara H, Narukawa M, Shuin T. Inoue K, et al. Photodiagnosis Photodyn Ther. 2015 Jun;12(2):193-200. doi: 10.1016/j.pdpdt.2015.03.008. Epub 2015 Apr 2. Photodiagnosis Photodyn Ther. 2015. PMID: 25843912 Clinical Trial.
40 results